Suraksha Diagnostic Limited (NSE:SURAKSHA)
India · Delayed Price · Currency is INR 305.40
+1.35 (0.44%)
Sep 9, 2025, 11:24 AM IST
Suraksha Diagnostic Revenue
Suraksha Diagnostic had revenue of 734.92M INR in the quarter ending June 30, 2025, with 21.01% growth. This brings the company's revenue in the last twelve months to 2.64B, up 18.41% year-over-year. In the fiscal year ending March 31, 2025, Suraksha Diagnostic had annual revenue of 2.52B with 15.26% growth.
Revenue (ttm)
2.64B
Revenue Growth
+18.41%
P/S Ratio
6.00
Revenue / Employee
2.03M
Employees
1,300
Market Cap
15.84B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 2.52B | 333.84M | 15.26% |
| Mar 31, 2024 | 2.19B | 285.75M | 15.03% |
| Mar 31, 2023 | 1.90B | -330.59M | -14.81% |
| Mar 31, 2022 | 2.23B | 831.87M | 59.42% |
| Mar 31, 2021 | 1.40B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 537.77B |
| Divi's Laboratories | 96.52B |
| Cipla | 274.80B |
| Apollo Hospitals Enterprise | 225.51B |
| Mankind Pharma | 129.10B |
| Zydus Lifesciences | 236.08B |
| Fortis Healthcare | 80.94B |
| Alkem Laboratories | 133.04B |